Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV000002743 | SCV002021258 | pathogenic | Marinesco-Sjögren syndrome | 2019-07-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000002743 | SCV003000567 | pathogenic | Marinesco-Sjögren syndrome | 2024-08-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg111*) in the SIL1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SIL1 are known to be pathogenic (PMID: 16282977, 24176978). This variant is present in population databases (rs119456965, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Marinesco-Sjogren syndrome (PMID: 16282977, 21873089). ClinVar contains an entry for this variant (Variation ID: 2625). For these reasons, this variant has been classified as Pathogenic. |
3billion | RCV000002743 | SCV005905962 | pathogenic | Marinesco-Sjögren syndrome | 2023-06-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000002625 /PMID: 16282977). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV000002743 | SCV000022901 | pathogenic | Marinesco-Sjögren syndrome | 2007-03-01 | no assertion criteria provided | literature only |